"This is a very exciting time in the fight against TB as politicians, public health officials, researchers, donor agencies, and foundations worldwide refocus their attention on the pandemic caused by the age-old pathogen Mycobacterium tuberculosis.
Multi-disciplinary research combining epidemiologic studies and clinical trials in TB endemic countries with modern microbiology, immunology, and genetics is essential to make progress in the fight against TB.
The NIH-funded Tuberculosis Research Unit (TBRU) is a leader in interdisciplinary TB research. The TBRU aims not only to understand how M. tuberculosis infects, persists, and causes disease in humans, but also to translate that understanding into improving prevention, vaccines, diagnostics, and drug treatment for TB."
- W. Henry Boom M.D., TBRU Director